Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Fabre

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Scientific Reports|March 16, 2016
Proinflammatory isoforms of IL-32 as novel and robust biomarkers for control failure in HIV-infected slow progressorsMohamed El-Far, Pascale Kouassi, Mohamed Sylla, et al.
Science Translational Medicine|June 30, 2017
Type 2 immunity is protective in metabolic disease but exacerbates NAFLD collaboratively with TGF-βKevin M Hart, Thomas Fabre, Joshua C Sciurba, et al.
Science Immunology|April 7, 2023
Identification of a broadly fibrogenic macrophage subset induced by type 3 inflammationThomas Fabre, Alexander M S Barron, Stephen M Christensen, et al.
Biorxiv : the Preprint Server for Biology|April 17, 2023
Stricturing Crohn's disease single-cell RNA sequencing reveals fibroblast heterogeneity and intercellular interactionsPranab K Mukherjee, Quang Tam Nguyen, Jiannan Li, et al.
Gastroenterology|July 28, 2023
Stricturing Crohn's Disease Single-Cell RNA Sequencing Reveals Fibroblast Heterogeneity and Intercellular InteractionsPranab K Mukherjee, Quang Tam Nguyen, Jiannan Li, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Scientific Reports|March 16, 2016
Proinflammatory isoforms of IL-32 as novel and robust biomarkers for control failure in HIV-infected slow progressorsMohamed El-Far, Pascale Kouassi, Mohamed Sylla, et al.
Science Translational Medicine|June 30, 2017
Type 2 immunity is protective in metabolic disease but exacerbates NAFLD collaboratively with TGF-βKevin M Hart, Thomas Fabre, Joshua C Sciurba, et al.
Science Immunology|April 7, 2023
Identification of a broadly fibrogenic macrophage subset induced by type 3 inflammationThomas Fabre, Alexander M S Barron, Stephen M Christensen, et al.
Biorxiv : the Preprint Server for Biology|April 17, 2023
Stricturing Crohn's disease single-cell RNA sequencing reveals fibroblast heterogeneity and intercellular interactionsPranab K Mukherjee, Quang Tam Nguyen, Jiannan Li, et al.
Gastroenterology|July 28, 2023
Stricturing Crohn's Disease Single-Cell RNA Sequencing Reveals Fibroblast Heterogeneity and Intercellular InteractionsPranab K Mukherjee, Quang Tam Nguyen, Jiannan Li, et al.
Pageof 2